Latest Breaking News On - Oasmia pharmaceutical - Page 5 : comparemela.com

Orexo appoints Fredrik Järrsten as new CFO

/PRNewswire/ Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY), announces today that the company has appointed Fredrik Järrsten as new Chief Financial Officer (CFO).

United statesUppsala lanLena wangeJoe defeoNikolaj sorensenJoseph defeoIr communicationsOrexo press releaseKarolinska developmentChief financial officerOasmia pharmaceuticalNasdaq stockholm mid capPress release orexoPublished march

Social Media and Oncology: The Time Is Now

Social Media and Oncology: The Time Is Now
ascopubs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ascopubs.org Daily Mail and Mail on Sunday newspapers.

Rhode islandUnited statesBristol myers squibbPatriciaf andersonDons dizonRhode island department of healthAmerican society of clinical oncologyNational cancer instituteMy institutionWarren alpert medical school of brown universityResearch fundingStanford cancer instituteLifespan cancer instituteSocial mediaRhode island departmentWarren alpert medical school

Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Upgraded at Zacks Investment Research

Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Upgraded at Zacks Investment Research
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Uppsala lanJulian aleksovZacks investment researchOasmia pharmaceuticalInvestment researchDoxophos vet

Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treat

European Commission and MHRA approves transfer of marketing authorization from Oasmia Pharmaceutical AB to Inceptua AB

United kingdomInceptua pharmaNicole anscombe coxClive whitcherStefan fraenkelElevar therapeutics incDear editorial teamEuropean commissionInceptua groupRegulatory agencyEditorial teamUnited kingdom medicinesOasmia pharmaceuticalLife science newswireChief executive officerElevar therapeutics

Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Downgraded by Zacks Investment Research

Oasmia Pharmaceutical AB (publ) (OTCMKTS:OASMY) Downgraded by Zacks Investment Research
etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.

Uppsala lanJulian aleksovZacks investment researchOasmia pharmaceuticalDoxophos vetHang seng